Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for MediWound Ltd. (MDWD : NSDQ)

• Company Description    MediWound Ltd. is a biotechnology niche specialty company. It is focused on developing, manufacturing and commercializing products that address unmet needs in the fields of severe burn and chronic wound management. The company is also developing NexoBrid for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns. MediWound Ltd. is headquartered in Yavne, Israel. Number of Employees: 121

• Price / Volume Information    Yesterday's Closing Price: $12.00 Daily Weekly Monthly 20 Day Moving Average: 89,131 shares Shares Outstanding: 12.85 (millions) Market Capitalization: $154.22 (millions) Beta: 0.09 52 Week High: $19.70 52 Week Low: $11.84 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -13.23% -12.32% 12 Week -14.89% -16.97% Year To Date -34.99% -41.06%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 42 HAYARKON STREET - YAVNE,L3 8122745 ISR ph: 972-77-971-4100 fax: 972-77-971-4111 ir@mediwound.com http://www.mediwound.com

• General Corporate Information    Officers Ofer Gonen - Chief Executive Officer Nachum Shamir - Chairman Shmulik Hess - Chief Operating Officer & Chief Commercial Officer Hani Luxenburg - Chief Financial Officer Yaron Meyer - Executive Vice President; General Counsel and Corp Peer Information MediWound Ltd. (GSAC) MediWound Ltd. (CASIF) MediWound Ltd. (ALCD.) MediWound Ltd. (OMNN) MediWound Ltd. (CGPI.) MediWound Ltd. (CATX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-DRUGS Sector: Medical CUSIP: M68830112 SIC: 2833 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/26 Next Expected EPS Date: 11/19/26 Share - Related Items Shares Outstanding: 12.85 Most Recent Split Date: 12.00 (0.14:1) Beta: 0.09 Market Capitalization: $154.22 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.63 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-2.37 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/19/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 4.33 Price/Cash Flow: - Price / Sales: 13.00 EPS Growth vs. Year Ago Period: 37.40% vs. Previous Quarter: -234.78% Sales Growth vs. Year Ago Period: -45.83% vs. Previous Quarter: 109.63% ROE 09/30/26 - - 06/30/26 - -47.24 03/31/26 - -67.22 ROA 09/30/26 - - 06/30/26 - -24.27 03/31/26 - -31.87 Current Ratio 09/30/26 - - 06/30/26 - 2.32 03/31/26 - 2.41 Quick Ratio 09/30/26 - - 06/30/26 - 2.09 03/31/26 - 2.19 Operating Margin 09/30/26 - - 06/30/26 - -170.10 03/31/26 - -180.30 Net Margin 09/30/26 - - 06/30/26 - -170.10 03/31/26 - -180.30 Pre-Tax Margin 09/30/26 - - 06/30/26 - -168.90 03/31/26 - -179.28 Book Value 09/30/26 - - 06/30/26 - 2.77 03/31/26 - 3.22 Inventory Turnover 09/30/26 - - 06/30/26 - 2.31 03/31/26 - 2.72 Debt-to-Equity 09/30/26 - - 06/30/26 - 0.00 03/31/26 - 0.00 Debt-to-Capital 09/30/26 - - 06/30/26 - 0.00 03/31/26 - 0.00

Powered by Zacks Investment Research ©